SCHEMBL4366779

SCHEMBL4366779

CC(C)(C)C(I)(NC(=O)c1cc(F)cc(F)c1)Nc1c(Nc2cnccn2)c(=O)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPKAPK2 P49137 2/20 0.36
TSHR P16473 2/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LCK P06239 2/20 0.33
HIF1A Q16665 1/20 0.33
KMT2A Q03164 2/20 0.33
GSK3A P49840 2/20 0.32
GSK3B P49841 2/20 0.32
CDK5 Q00535 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4366799 0.78 MAPKAPK2 (0.42) NPC1TP53MAPTNFKB1RAB9A
SCHEMBL4366803 0.77 NPC1 (0.36) NPC1TP53MAPTNFKB1RAB9A
SCHEMBL12784950 0.65 MAPKAPK2 (0.45) NPC1TP53MAPTNFKB1RAB9A
SCHEMBL6990875 0.62 PLK1 (0.36) MAPKAPK2KMT2AGSK3AGSK3BPLK1
SCHEMBL1368536 0.61 JAK2 (0.58) NPC1TP53MAPTNFKB1RAB9A
SCHEMBL1368538 0.61 JAK2 (0.58) NPC1TP53MAPTNFKB1RAB9A
SCHEMBL6419841 0.61 SLC6A3 (0.53) NPC1MAPTRAB9AKMT2AGRM5
SCHEMBL6987283 0.61 KMT2A (0.44) MAPKAPK2TSHRALOX15CASP1NPSR1
SCHEMBL6987810 0.61 ABCC9 (0.47) NPC1RAB9AMAPKAPK2KMT2AGSK3A
SCHEMBL6985552 0.60 GAA (0.35) NPC1RAB9ASMN1; SMN2MAPKAPK2GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009012375-A2 SQUARATE KINASE INHIBITORS WYETH (US) 2009-01-22 WO disclosed